House Hearing Examines FDA’s Role in US Drug Innovation

Live News Network
1.4K followers
Jul 15, 2026
The House Energy and Commerce Committee holds a hearing at 10:15 a.m. ET on July 15 to examine the Food and Drug Administration’s role in supporting biomedical innovation.
AI Generated·May contain errors
Video Summary
AI GeneratedThis congressional hearing examines strategies to maintain U.S. leadership in biomedical innovation amid rising global competition, particularly from China. Discussions focus on modernizing FDA regulatory frameworks, protecting scientific integrity from political interference, increasing clinical trial diversity, and securing federal funding to prevent a \"brain drain\" of research talent.
